3rd Quarter - Report

WEST FRONT STRATEGIES LLC for FRESENIUS KABI USA LLC

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

Issues related to patent policy and reform, including to address patent thickets (HR 6986, S. 3583) and Promoting and Respecting Economically Vital American Innovation Leadership Act (S. 2220, HR 4370), and Patent Eligibility Restoration Act of 2023 (S. 2140) FDA/PTO Coordination, including Interagency Patent Coordination and Improvement Act of 2023 (S.79) and Medication Affordability and Patent Integrity Act (S. 2780, HR 5429) Prescription Pricing for the People Act of 2023 (S.113); Preserve Access to Affordable Generics and Biosimilars Act (S.142); Affordable Prescriptions for Patients Act of 2023 (S.150).

LobbyistCovered position, as disclosed
CHRISTOPHER BUKI —
ASHLEY DAVIS —
CRAIG KALKUT —
MALLOY MCDANIEL —
KRISTI REMINGTON —
SHIMON STEIN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 79 (118th), S. 142 (118th), S. 113 (118th), S. 2140 (118th), S. 2780 (118th), S. 2220 (118th), S. 3583 (118th), H.R. 5429 (118th), S. 150 (118th), H.R. 4370 (118th), H.R. 6986 (118th)

Medicare/Medicaid MMM

Formulary placement of generics and biosimilar biological products in Part D; issues related to access to biosimilar biological products in Medicare Part B; issues related to rebate walls.

LobbyistCovered position, as disclosed
CHRISTOPHER BUKI —
ASHLEY DAVIS —
CRAIG KALKUT —
MALLOY MCDANIEL —
KRISTI REMINGTON —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Issues related to drug pricing; issues related to Biosimilars; issues related to competition; issues related to drug shortages; DRUG Act (HR 6283, S. 1542).

LobbyistCovered position, as disclosed
CHRISTOPHER BUKI —
ASHLEY DAVIS —
CRAIG KALKUT —
MALLOY MCDANIEL —
KRISTI REMINGTON —
SHIMON STEIN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 6283 (118th), S. 1542 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.